![]() |
|
|
4 Department of Pediatrics, University of Florida, Gainesville, FL, 32610-0296 and 5 Mead Johnson Nutritionals, Evansville, Indiana 47721-0001
* To whom correspondence should be addressed. E-mail: neuj{at}peds.ufl.edu.
| ABSTRACT |
|---|
|
|
|---|
B (I
B) and ubiquitinated-I
B (Ub-I
B) expression by immunoblotting and nuclear factor (NF)
B localization by immunofluorescence staining. Flagellin induced a 17-fold increase in IL-8 production compared with control (P < 0.05), whereas pretreatment with either live LGG or UV-inactivated LGG resulted in 66 and 59% decreases, respectively, compared with the flagellin group (P < 0.05). Flagellin-induced NF
B nuclear translocation was prevented by both live and UV-inactivated LGG. Flagellin decreased I
B, which was reversed by either live or UV-inactivated LGG (P < 0.05). UV-inactivated LGG decreased Ub-I
B expression (P < 0.05), although live LGG had no effect. This study supports the concept that UV-inactivated and live LGG are equally effective in decreasing IL-8 production in the intestinal epithelium. Although the mechanism involves different pathways, both alter cytoplasmic I
B, thereby inhibiting NF
B nuclear translocation.
| Introduction |
|---|
|
|
|---|
Probiotics are live microbial agents that can be supplemented to putatively replenish the GI microbiota and maintain intestinal homeostasis; however, the mechanisms of probiotic action remain poorly understood. The strain Lactobacillus rhamnosus GG (LGG) has been used as a probiotic in several studies (9) showing beneficial effects on the host, including modulation of inflammation. Our previous studies demonstrate that live or heat-inactivated LGG are able to modulate tumor necrosis factor-
(TNF
)-induced interleukin-8 (IL-8) production in the intestinal epithelium (10), but further insights into mechanisms of action are still required, including analysis of whether this response can be protective against other proinflammatory agents such as flagellin. Because of the potential impact heat treatment has on cellular integrity and protein structure, additional studies are also needed to determine whether alternative methods such as UV radiation can be used to inactivate probiotics and retain beneficial functions.
The inflammatory response in the GI tract involves the inhibitor of
B (I
B)/nuclear factor (NF)
B complex. NF
B is a nuclear transcription factor that activates the synthesis of cytokines and chemokines (11). NF
B is usually bound in the cytoplasm to the inhibitory molecule I
B, but in response to certain stimuli, phosphorylation, ubiquitination, and proteolysis of I
B occur, resulting in NF
B nuclear translocation and proinflammatory mediation (11). The GI tract appears to be tolerant to certain commensal bacteria, because they inhibit the degradation of I
B, thereby preventing NF
B translocation (12).
The potential for bacterial overgrowth in the intestine, not only of endogenous microbes but also those introduced therapeutically or prophylactically, is of concern, especially in immunosuppressed individuals (13–15). This concern could be obviated with the administration of inactive bacteria, because they have lost their ability to self-replicate. Here, the objective was to determine whether inactivated LGG could modulate inflammation in intestinal epithelial cells (specifically the Caco-2 cell line) similarly to live agents. IL-8, a proinflammatory chemokine released by intestinal epithelial cells, was used as a measurement of inflammation. High levels of IL-8 reflect an inflammatory response to the harmful effects of a destructive microorganism. Flagellin, a protein component of Pseudomonas aeruginosa, is a powerful proinflammatory stimulant that induces intestinal injury (16,17). We hypothesized that UV-inactivated LGG administered before the inflammatory stimulus flagellin would modulate IL-8 production by inhibiting the nuclear translocation of NF
B.
| Materials and Methods |
|---|
|
|
|---|
B
, NF
B p65, and Protein A-agarose beads were obtained from Santa Cruz Biotechnology. Cell culture. Caco-2 cells were obtained from American Type Culture Collection and grown in a humidified incubator at 37°C under 5% CO2, 95% air. For each experiment, Caco-2 cells (passage 15–28) were collected by dissociation of a confluent stock culture with 0.25% trypsin and 1 mmol/L EDTA. Full culture media consisted of glutamine-free minimum essential medium supplemented with 20% fetal bovine serum, 4 mmol/L glutamine, 100 kU/L penicillin, 100 mg/L streptomycin, 0.25 mg/L amphotericin B, 1 mmol/L sodium pyruvate, and 0.15% sodium bicarbonate. Media were changed 3 times per week. The cells were grown in triplicate in each group. Although full confluency was reached after 1 wk, experiments were initiated on d 14–15 after seeding. Previous studies in our laboratory have shown this is a time at which the cells begin to express alkaline phosphatase activity and are in an early stage of differentiation, corresponding to the upper crypt-lower villus stage of differentiation. The experiments were continued for 24–72 h as the cells progressed through more mature stages of differentiation.
Bacteria and related preparations.
Live LGG was stored at 4°C. The activity of this powder was
3.6 x 1011 colony-forming units (cfu)/g. Live LGG was suspended in cell culture media without antibiotics. UV-inactivated LGG were prepared by exposing LGG under a 39-W germicidal UV lamp for 5 min at a distance of 10 cm and then diluted in cell culture media without antibiotics. Before adding to each well, the LGG solution was vortexed and pipetted to ensure that a uniform dose was entered in each well. Effectiveness of the UV inactivation method was confirmed as follows: 0.2 mL of samples of LGG before and after UV exposure were diluted in PBS and plated on L agar. The plates were incubated under anaerobic conditions for 72 h at 37°C. The untreated sample was at 5.4 x 1010 cells/L. The minimal level of detection is 5000 cells/L and no colonies were detected from the 0.2-mL UV-inactivated sample.
Expression and purification of flagellin. Flagella were purified from P. aeruginosa strains grown overnight in Luria-Bertani broth. Flagella were mechanically sheared from the surface of the bacteria and collected by ultracentrifugation. The purification and extraction process was performed as previously described (18).
ELISA for IL-8. Cells were seeded onto 12-well plates (Costar, Corning) at a density of 2–3 x 105 cells/cm2. Monolayers were rinsed with PBS once and then pretreated with antibiotic-free medium containing 0 (LGG 0) or 1011 cfu/L (LGG 1011) of live or inactivated LGG for 24 h. Cells were pretreated with LGG to determine whether this treatment might blunt the marked increase in IL-8 production induced by flagellin. Cells were stimulated with or without flagellin (500 µg/L) in the culture media for 48 h to ensure an adequate amount of time for stimulation. This dose of flagellin was determined by preliminary studies (18). The control group received the same cell culture media without LGG and flagellin. Cell culture media were collected and frozen at –20°C for determination of the concentrations of IL-8 by ELISA (OptEIA, PharMingen). High Binding Extra 96-well microtiter plates (IMMULON4HBX, Dynex Technologies) were used to quantify cytokines as described by the manufacturer. We read plates at 450 nm using a microplate reader (PowerWaveX Bio-TEK Instruments). Protein concentrations of whole cell lysates were measured using the BioRad Dc protein Assay (BioRad). IL-8 levels were normalized to standard protein concentrations.
Immunoblotting.
Cells (6–8 x 104 cells/cm2) in 100-nm-diameter dishes were cultured for 14 d. Cells were stimulated with or without flagellin (500 µg/L) in the media for 5, 10, 15, and 30 min. These times were chosen to determine maximum I
B
degradation, which occurred at 15 min.
After incubation with different concentrations (LGG 0 or LGG 1011) of live or inactivated LGG for 24 h, cells were stimulated with flagellin (500 µg/L) for 15 min and I
B
degradation measured by immunoblotting. The control group received the same cell culture media without LGG and flagellin. After treatment, cells were washed in PBS and suspended in lysis buffer [50 mmol/L Tris-HCL, pH 7.4, 150 mmol/L NaCl, 0.5% NP-40, 50 mmol/L NaF, 1 mmol/L Na3VO 4, ddH2O, and 1x complete protease inhibitor cocktail (Roche Molecular Biochemicals)]. After cells were lysed, the solution was centrifuged at 10,000 x g; 10 min at 4°C and the cleared lysates (cytoplasmic fragments) collected. Once we determined the protein concentration of cleared lysates using BioRad Dc Protein Assay, we separated equal amounts of protein using a 12.5% SDS-PAGE. Electrophoresed proteins were transferred from the gel to a polyvinylidene difluoride membrane. After transfer, the membrane was also stained with amido black to ensure appropriate protein transfer and equal loading of proteins. The membrane was blocked with 5% nonfat dry milk in Tris-buffered saline with Tween 20, incubated with primary antibody (anti-I
B
, 1:1000), and then with the appropriate horseradish peroxidase-conjugated secondary antibody (1:1000). The blot was developed using enhanced chemiluminescence (ECLplus, Amersham Pharmacia Biotech) according to the manufacturer's instructions. Protein bands were quantified by densitometry using Adobe Photoshop software.
Immunoprecipitation of ubiquitinated-I
B
.
After the cells were incubated with different concentrations (LGG 0 or LGG 1011) of live or inactivated LGG for 24 h, they were treated with 50 µmol/L MG-132 for 1 h before stimulation with flagellin (500 µg/L) for 15 min. The control group received the same cell culture media without LGG and flagellin. Cytoplasmic extracts (200 µg of protein), made up to 100 µL with buffer [20 mmol/L Tris, pH 7.5, 150 mmol/L NaCl, 1.0 mmol EDTA, 1.0 mmol/EGTA, 1% Triton X-100, 1.0 mmol/L sodium vanadate, and 1x complete protease inhibitor mixture (Roche Molecular Biochemicals)], were incubated overnight at 4°C with primary antibody (anti-I
B
, 1:100). The samples were then treated with 30 µL of protein A-agarose beads for 2 h at 4°C. The samples were then centrifuged and washed 5 times in buffer at 1000 x g for 30 s. The beads were boiled in SDS-PAGE sample treatment buffer and electrophoresed on a 10% SDS-PAGE. The gel was blotted and incubated with a monoclonal antibody to ubiquitin (1:500). Antigen-antibody complexes were detected with enhanced chemiluminescence (Amersham Pharmacia Biotech).
NF
B immunofluorescence staining.
Cells were cultured in an 8-well slide and treated with different concentrations (LGG 0 or LGG 1011) of live or inactivated LGG for 24 h and then stimulated with flagellin (500 µg/L) for 1 h. The control group received the same cell culture media without LGG and flagellin. Cells were washed with PBS and then fixed with 3% paraformaldehyde. After blocking, a primary antibody (anti-NFkB, 1:50) was added and the slide incubated for 1 h. The slide was then incubated in the dark for 1 h with an fluorescein isothiocyanate -labeled secondary antibody (1:100). Cells were mounted and viewed with a fluorescence microscope.
Statistical analysis. Values are given as means ± SD of triplicate measurements. One-way ANOVA were performed to determine whether live or UV-inactivated LGG affects the flagellin-induced IL-8 production by intestinal epithelial cells. We performed multiple comparisons of means using Tukey's test. When variances were not homogeneous, nonparametric Kruskal-Wallis comparisons of ranks were made. Sigma Stat software (SPSS Science) was used for all analyses and differences among means were considered significant at P < 0.05.
| Results |
|---|
|
|
|---|
|
Effect of LGG on flagellin-induced I
B-
degradation and ubiquitination.
Whereas flagellin downregulated I
B expression compared with control, both live and UV-inactivated LGG reversed this effect (P < 0.05) (Fig. 1B). The increase in I
B suggests that both live and UV-inactivated LGG inhibited I
B degradation or altered its synthesis to a similar degree.
Compared with control, flagellin increased ubiquitinated-I
B (Ub-I
B) (P < 0.05). Live LGG and UV-inactivated LGG affected Ub-I
B expression differently; live LGG did not affect the flagellin-induced increase in Ub-I
B, whereas UV-inactivated LGG decreased Ub-I
B expression (P < 0.05) (Fig. 1C). This suggests that live and UV-inactivated LGG effects on IL-8 production and I
B expression may be through different pathways despite the fact that they both involve I
B and NF
B.
Effect of LGG on flagellin-induced nuclear NF
B p65 expression.
Both live and UV-inactivated LGG inhibited NF
B nuclear translocation, whereas flagellin induced NF
B nuclear translocation. The control and groups pretreated with live or UV-inactivated LGG and then stimulated by flagellin showed cytosolic NF
B staining, which indicates that I
B was not degraded and remained bound to NF
B in the cytoplasm. The cells stimulated by flagellin showed nuclear NF
B staining, indicating that I
B was degraded and NF
B translocated to the nucleus to induce inflammatory cytokine synthesis (Supplemental Fig. 1).
| Discussion |
|---|
|
|
|---|
B and NF
B steps, despite differing effects on the ubiquitination of I
B. Despite the recent enthusiasm for probiotic usage, there are cautionary warnings about indiscriminant manipulation of the GI microbiota during the perinatal and neonatal time periods and in individuals who may be immunosuppressed (13–15). The short-term consequences consist of bacterial translocation and sepsis, whereas long-term effects are poorly studied but need to be considered, especially in neonatal populations where the intestinal microbiota are in the early phases of becoming established (13). Consequences include the possibility of overstimulation of the inflammatory response (10) with these live organisms in compromised hosts, particularly critically ill preterm neonates (19–21) and adults (22,23), and also the potential of detrimental long-term effects, such as autoimmunity, allergies, and atopy (24,25).
The rationale for using inactivated agents stems from studies showing that interactions of microbe-associated molecular patterns with toll-like receptors (TLR) and other mucosal pattern recognition receptors likely mediate some of the beneficial responses of probiotics. Microbial components that are TLR receptor ligands and even killed probiotics have been demonstrated to be protective if given prior to administration of agents that are injurious to the intestine (10,26–28). For example, cytosine-phosphate-guanine (29) or even TLR agonists such as lipopolysaccharide and lipoteichoic acid (28) in low doses may be effective in promoting the inhibitory actions of the intestinal epithelium in the signaling cascade of the inflammatory response (30). Use of such agents may in certain circumstances be safer than use of live agents, as previously mentioned. Further work on specific mechanisms is needed to delineate what is actually being done by the inactivated agents and if this is similar to the mechanisms of the live agents.
A previous study by our group evaluated the effects of live and heat-killed LGG on TNF
-induced IL-8 production through the NF
B pathway (10). The results showed that both forms of LGG have the ability to downregulate TNF
-induced IL-8 production in Caco-2 cells. When cells were treated with live or heat-killed LGG alone, IL-8 production increased noticeably. The effects were much less evident in cells treated with heat-killed LGG, suggesting that the heat-killed form may be safer than live LGG. The study also showed the prevention of NF
B nuclear translocation when cells were pretreated with LGG. We had similar results in our current study, where both forms of LGG modulated flagellin-induced IL-8 production and when given alone, UV-inactivated LGG did not cause a significant increase in IL-8. If inactivated probiotics provide the beneficial properties of live bacteria, they may be safer alternatives, because the dose of these agents can be readily controlled and they are less likely to establish lifelong niches that may be difficult to undo.
The flagellin of P. aeruginosa was utilized, because previous studies have demonstrated that this agent serves as a strong proinflammatory stimulus, increasing IL-8 production via activation of TLR 5. This flagellin contains a hook structure and its motility allows for it to infect intestinal epithelial cells, thereby activating NF
B (16). Although numerous intracellular signaling pathways may be involved, we focused on the I
B/NF
B pathway. Previous studies where flagellin induced IL-8 production in immature (H4 cells) and mature (T84 cells) enterocytes showed that increased production of chemokines was caused by decreased levels of I
B expression and activation of NF
B nuclear translocation (12).
Our studies of mechanisms of live and UV-inactivated LGG showed an upregulation of I
B, allowing for modulation of the inflammatory response. The I
B/NF
B complex exists in the cytoplasm of the cell, which is disrupted when the cell receives extracellular signals such as the presence of a bacterial ligand. After a signaling cascade, I
B degrades and allows NF
B to translocate to the nucleus, activating the expression of genes that allow IL-8 production to occur. This study demonstrates that LGG prevents the degradation of I
B, allowing the I
B/NF
B complex to remain in the cytoplasm and blocking the transcription of genes that lead to IL-8 production. Lack of NF
B nuclear translocation in the control and groups treated with live or UV-inactivated LGG suggests that LGG maintains the inflammatory cascade in a similar condition as the control.
Because ubiquitination of I
B is needed for its degradation, the effects of LGG on flagellin-induced ubiquitination of I
B were also studied. Our studies determined that UV-inactivated LGG decreased Ub-I
B expression, although live LGG had no effect. Studies by Neish et al. (11) suggest that the GI epithelium is tolerant to certain commensal bacteria because of their ability to decrease ubiquitination of I
B. Because our study shows that live LGG does not alter the level of I
B ubiquitination that is induced by flagellin, other possibilities such as alternative signaling pathways remain to be evaluated.
In summary, our results show that live LGG and UV-inactivated LGG significantly decrease IL-8 production in Caco-2 cells. Although further investigation is needed to understand the mechanism by which this occurs, UV-inactivated LGG may be a promising and safer alternative to live therapeutic microbial agents in at risk individuals.
| FOOTNOTES |
|---|
2 Author disclosures: N. Li, M. Lopez, J. Kataria, M. Russell, and J. Neu, no conflicts of interest. ![]()
3 Supplemental Figure 1 is available with the online posting of this article at jn.nutrition.org. ![]()
6 Abbreviations used: cfu, colony-forming unit; GI, gastrointestinal; I
B, inhibitor of
B; IL-8, interleukin 8; LGG, Lactobacillus rhamnosus GG; LPS, lipopolysaccharide; LTA, lipotechoic acid; NF, nuclear factor; SIRS, systemic inflammatory response syndrome; TLR, toll-Like receptor; TNF
, tumor necrosis factor-
; Ub-IkB, ubiquitinated-IkB. ![]()
Manuscript received 30 May 2008. Initial review completed 25 June 2008. Revision accepted 8 August 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. Rautava S, Walker WA. Commensal bacteria and epithelial cross talk in the developing intestine. Curr Gastroenterol Rep. 2007;9:385–92.[Medline]
2. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol. 2004;12:129–34.[CrossRef][Medline]
3. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115–8.
4. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr. 2003;78:675–83.
5. Alverdy JC, Chang EB. The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away. J Leukoc Biol. 2008;83:461–6.
6. Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract. 2007;22:174–82.
7. Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr Suppl. 2005;94:100–5.[CrossRef][Medline]
8. Othman M, Agüero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol. 2008;24:11–6.[Medline]
9. Santosa S, Farnworth E, Jones PJ. Probiotics and their potential health claims. Nutr Rev. 2006;64:265–74.[CrossRef][Medline]
10. Zhang L, Li N, Caicedo R, Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-{alpha}-induced interleukin-8 production in Caco-2 cells. J Nutr. 2005;135:1752–6.
11. Neish AS. The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect. 2002;4:309–17.[CrossRef][Medline]
12. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA. 2004;101:7404–8.
13. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev. 2007;65:282–5.[CrossRef][Medline]
14. Liong MT. Safety of probiotics: translocation and infection. Nutr Rev. 2008;66:192–202.[CrossRef][Medline]
15. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83:1256–64.
16. Gewirtz AT. Flag in the crossroads: flagellin modulates innate and adaptive immunity. Curr Opin Gastroenterol. 2006;22:8–12.[Medline]
17. Petrof EO, Musch MW, Ciancio M, Sun J, Hobert ME, Claud EC, Gewirtz A, Chang EB. Flagellin is required for Salmonella-induced expression of heat shock protein Hsp25 in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2008;294:G808–18.
18. Verma A, Arora SK, Kuravi SK, Ramphal R. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun. 2005;73:8237–46.
19. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115:178–81.
20. Kunz AN, Fairchok MP, Noel JM. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;116:517.
21. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005;24:278–80.[CrossRef][Medline]
22. Riquelme AJ, Calvo MA, Guzmán AM, Depix MS, García P, Pérez C, Arrese M, Labarca JA. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol. 2003;36:41–3.[CrossRef][Medline]
23. Rijnders BJ, Van Wijngaerden E, Verwaest C, Peetermans WE. Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Med. 2000;26:825.[CrossRef][Medline]
24. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911–20.
25. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut. 2005;54:317–20.
26. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004;126:520–8.[CrossRef][Medline]
27. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest. 2005;115:695–702.[CrossRef][Medline]
28. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–41.[CrossRef][Medline]
29. Lee J, Rachmilewitz D, Raz E. Homeostatic effects of TLR9 signaling in experimental colitis. Ann N Y Acad Sci. 2006;1072:351–5.[CrossRef][Medline]
30. Shibolet O, Podolsky DK. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1469–73.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||